SOURCE: Bio-IT World

October 10, 2007 09:30 ET

Bio-IT World Expo Announces 2008 Keynote Speakers

NEEDHAM, MA--(Marketwire - October 10, 2007) - Bio-IT World has announced the three keynote speakers for its sixth annual Conference & Expo, to be held in Boston next Spring (April 28-30).

The keynoters will be Linda Avey, co-founder of 23andMe; Joshua Boger, president & CEO of Vertex Pharmaceuticals; and John Reynders, CIO, Johnson & Johnson Life Sciences Division.

Linda Avey is the co-founder of 23andMe, the Bay Area consumer genomics start-up. She previously worked in sales and business development for Affymetrix and Perlegen Sciences. Prior to that, Linda had stints at Spotfire and Applied Biosystems. Avey founded 23andMe with Anne Wojcicki, wife of Google co-founder Sergey Brin (Google is also an investor in 23andMe). Partnering with Illumina, 23andMe will shortly unveil a consumer genotyping service offering individuals whole-genome analysis to learn about genealogy, ancestry, and medical issues. Avey will speak on Wednesday morning, April 30, 2008.

Joshua Boger, PhD, is founder, president and CEO of Vertex Pharmaceuticals. Boger has served as CEO since 1992, and has also served as Chairman and president, and chief scientific officer. Prior to founding Vertex in 1989, Boger was senior director of basic chemistry at Merck Sharp & Dohme Research Laboratories, where he headed research groups in medicinal and biophysical chemistry. Boger holds a B.A. in chemistry and philosophy from Wesleyan University and M.S. and Ph.D. degrees in chemistry from Harvard University. Boger's early years at Vertex were feature in Barry Werth's classic biotechnology book, The Billion Dollar Molecule. Boger's talk will be on Tuesday morning, April 29, 2008.

John Reynders, PhD, is the newly appointed CIO for Johnson & Johnson's Life Sciences Division. He was previously the Information Officer for Lilly Research Laboratories - discovery and development informatics. Reynders joined Lilly from Celera, where he was VP for Informatics and Information Systems, where he was responsible for all supercomputing capabilities, discovery software engineering, and enterprise system infrastructure. Reynders joined the Los Alamos National Laboratory in 1992, where he served as the Director of the Advanced Computing Laboratory. Reynders received his PhD in applied and computational mathematics from Princeton University. Reynders will deliver the opening keynote on Monday afternoon, April 28, 2008.

Commented Bio-IT World Editor-in-Chief Kevin Davies: "We are absolutely thrilled to have three such outstanding scientists and visionaries accept our keynote invitations. John Reynders has been a frequent speaker at Bio-IT World events, but his new appointment as CIO for J&J's life sciences division will lend his expertise and talents in building informatics workflows for drug discovery even greater weight.

"Josh Boger has led Vertex for almost two decades since its inception, and thus brings unparalleled perspective and experience to the evolving challenges and opportunities facing drug development organizations both large and small.

"Finally, we are really delighted that 23andMe's Linda Avey has agreed to present at Bio-IT World. Her new company is one of the most exciting stories in genetics and medicine, and I expect a huge audience on hand to hear how she and her colleagues plan to read, interpret, and disseminate individual genome data."

For more information on Bio-IT World Conference & Expo, visit the event Web site at www.bio-itworldexpo.com.

About Bio-IT World www.bio-itworld.com

Bio-IT World -- the flagship publication of CHI -- is the leading source of news on technology and strategic innovation in drug discovery, development, and clinical trials. Bio-IT World's focus is increasingly one that explores the tools and results of "predictive biology" as the industry adapts to the new world of "personalized medicine." Bio-IT World has won 34 national and regional awards, more than any other magazine covering the life sciences industry. Bio-IT World was acquired by CHI in 2006 and is part of the Cambridge Healthtech Media Group -- a new group introduced by CHI in August 2007 -- that offers a suite of published resources that include Bio-IT World magazine, numerous topic-specific eNewsletters, and comprehensive, continually updated web sites.

About CHI www.healthtech.com

Founded in 1992, Cambridge Healthtech Institute (CHI) is the industry leader offering the preeminent source of information to the leading researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Events, Pharmaceutical Strategy Series, Insight Pharma Reports, Marketing Services, and Cambridge Healthtech Media Group.

Contact Information


  • Contact:
    Kaushik Chaudhuri
    Cambridge Healthtech Institute
    (781) 972-5419
    Email Contact